Paris - Delayed Quote EUR

Eurofins Scientific SE (ERF.PA)

Compare
49.19 +0.62 (+1.28%)
As of 1:55:48 PM GMT+1. Market Open.
Loading Chart for ERF.PA
DELL
  • Previous Close 48.57
  • Open 48.91
  • Bid --
  • Ask --
  • Day's Range 48.62 - 49.50
  • 52 Week Range 39.47 - 62.10
  • Volume 134,923
  • Avg. Volume 387,858
  • Market Cap (intraday) 9.226B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) 25.36
  • EPS (TTM) 1.94
  • Earnings Date Feb 25, 2025 - Mar 3, 2025
  • Forward Dividend & Yield 0.50 (1.03%)
  • Ex-Dividend Date Jul 3, 2024
  • 1y Target Est 59.46

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

www.eurofins.com

62,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ERF.PA

View More

Performance Overview: ERF.PA

Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ERF.PA
1.34%
CAC 40
1.50%

1-Year Return

ERF.PA
13.42%
CAC 40
0.03%

3-Year Return

ERF.PA
48.92%
CAC 40
0.63%

5-Year Return

ERF.PA
3.02%
CAC 40
22.82%

Compare To: ERF.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ERF.PA

View More

Valuation Measures

As of 1/3/2025
  • Market Cap

    9.07B

  • Enterprise Value

    11.93B

  • Trailing P/E

    25.04

  • Forward P/E

    13.02

  • PEG Ratio (5yr expected)

    0.54

  • Price/Sales (ttm)

    1.42

  • Price/Book (mrq)

    1.73

  • Enterprise Value/Revenue

    1.77

  • Enterprise Value/EBITDA

    8.95

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.64%

  • Return on Assets (ttm)

    4.85%

  • Return on Equity (ttm)

    7.27%

  • Revenue (ttm)

    6.72B

  • Net Income Avi to Common (ttm)

    325.9M

  • Diluted EPS (ttm)

    1.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    681.2M

  • Total Debt/Equity (mrq)

    66.91%

  • Levered Free Cash Flow (ttm)

    629.79M

Research Analysis: ERF.PA

View More

People Also Watch